Search results for: Precision Medicine
Filter search results
Personalised Medicine: Is it an Oil-Rush or Oil-Spill?
3 February 2020, 12:00am
OHE Lunchtime Seminar with Alistair McGuire, London School of Economics entitled “Personalised Medicine: Is it an Oil-Rush or Oil-Spill?” While there have been some remarkable successes to date, personalized medicine…
Why do we expect obesity medicines to work differently?
5 March 2026
…the study, who emphasises, “This [weight gain] isn’t a failing of the medicines – it reflects the nature of obesity as a chronic, relapsing condition.” The World Health Organization describes…
Benefiting from the Promise of Personalised Medicine: Recent OHE Presentations
18 February 2014
…all of a medicine’s uses. Rationale and Procedure for Oncology Pricing and Reimbursement in England Towse 2014 from Office of Health Economics Personalised medicine holds great promised for both improving…
Just Published: OHE Report on Trends in Scottish Medicines Committee Advice Decisions
25 February 2016
An analysis in the trends in Scottish Medicines Committee (SMC) advice decisions for medicines for the period October 2009 to September 2015 has just been published in an OHE Consulting…
Brand Names in Prescribing
1 September 1976
…when compliance with official standards does not guarantee in itself the quality of the medicine. Unfortunately, many physicians are not sufficiently aware that different medicines containing the same drug can…
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
1 March 2015
…always expanding, one important limitation is the difficulty in assessing medicine use according to what that medicine has been used for, where the medicine has multiple indications. This impedes our…
Around the World in HTAs: Spain – Closer than ever, but not quite yet
8 July 2026
…reforms – a draft Royal Decree on medicines pricing and reimbursement and a new Medicines and Medical Devices Bill – are still moving through the policy pipeline. Together, these texts…
Time Trends in NICE HTA Decision Making: Setting the Record Straight
21 May 2012
…remit to appraise all medicines when they are launched (in comparison to the Scottish Medicines Consortium, for example). Instead, the medicines that NICE considers are chosen by the Department of…
Around The World in HTAs: Italy – What’s Next?
20 April 2023
…price negotiation, reimbursement, and entry agreement negotiations) are mostly managed by the Regions. Assessment of medicines The assessment of new medicines is managed by the HTA & Pharmaceutical Economics Department…